Valuation

P/E--
P/B--
P/S--
EV/EBIT14.0

Business Strength

ROE1.5%
ROCE5.8%
OPM1.9%
NPM0.0%

Growth (3Y CAGR)

EPS-86.0%
Sales+4.0%
Profit-26.0%
3Y Return--

Balance Sheet

Debt/Equity0.3
Debt8.75 Cr
Pledge0.0%
CWIP/Fixed Asset0.0%

Cash Position

CFO/NP--
FCF-8.13 Cr
FCF 3Y Avg-10.4 Cr
Cash/MCap11.0%

Others

Div Yield0.0%
Div Payout0.0%
Cash Conv. Cycle85 days
Tradeable Free Float27.8%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
Sales
--
--
+4.0%
--
-29.0%
Decelerating
ROE
--
+6.0%
+7.0%
--
--
Accelerating
Return
--
--
--
-6.0%
--
--
Profit
--
--
-26.0%
--
-79.0%
Decelerating

Quarterly Results

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity0.27
Interest Coverage-2.7x
Promoter Pledge0.0%
Borrowings7 Cr

Efficiency

Receivable Days85 days
Inventory Days days
Payable Days days
Cash Conversion cycle85 days

Cash Position

Operating Cash Flow-8 Cr
Investing Cash Flow-1 Cr
Financing Cash Flow9 Cr
Free Cash Flow-8 Cr

Detailed Financials

Sales
Expenses
Operating Profit
Other Income
Interest
Depreciation
Profit Before Tax
Tax %
Net Profit
Exceptional Items
EPS (Rs)
Sales Growth (YoY)
Sales Growth (QoQ)
OP Growth (YoY)
OP Growth (QoQ)
Profit Growth (YoY)
EPS Growth (YoY)
EPS Growth (QoQ)
OP Margin
Net Margin
Material Cost %
Employee Cost %
P/S
P/E
P/B

Shareholding Pattern

Shareholders:357 (-22.1%)
Current MixMar 2026

Annual Reports

2

2025

2024